Companies in #ADC

Biotechnology company specializing in antibody-drug conjugate (ADC) technology for oncology. Entered a $1B collaboration with Genentech to develop next-generation ADCs targeting drug-resistance mechanisms in cancer.

Kelun-Biotech (Sichuan Kelun-Biotech Biopharmaceutical) is a biologics / adc company. See today's news for the latest developments.

Clinical-stage biotechnology company in Redmond, Washington, developing bispecific and multi-specific antibodies and antibody-drug conjugates for solid tumor and hematologic cancers; its September 2026 FDA IND clearance for SI-B037 was the company's first IND built on New Approach Methodologies.